Website Relaunch

by Dr Jan Roth

It has been a busy year so far and so I am not less pleased to present to you the relaunched website created by the wonderful design studio rothblau. I would be very happy to get feedback on the new website.

Project requests can be submitted via contact form as before or via jan.roth@epidemos.ch.

Happy to hear from you!

Here’s more

Open Science

Open Science is becoming standard. Not least, it is a prerequisite of many funding agencies that ...

Continue reading >>

Package inflation!

Today I'm not talking about the increase in parcel post, but about statistical software ...

Continue reading >>

What the hell is a “retrospective analysis”?

Many studies are titled ...

Continue reading >>

You Only Live Twice?

Have you ever heard of competing risks in clinical research? It’s a relevant concept ...

Continue reading >>

Side Note: Analytical Overkill

With biomedical statistics, information can be abstracted from a wide range of sources to make data understandable and actionable. This step is reductionistic. For example...

Continue reading >>

Side Note: Know-it-alls

As an author, editor and methodological reviewer, I experience from time to time that only one methodological approach is considered correct...

Continue reading >>

Side Note: Clarity in Research

epi demos has helped a variety of experts to enhance their research reports. What often stands out is that even specialists with decades of experience in research...

Continue reading >>

Side Note: Creativity in Research

Despite all the necessary efforts to standardize clinical research, we should not forget that research per se is an inherently creative process and that exploratory analyses...

Continue reading >>

More Predictors: Slightly Better Predictions but Increased Complexity

In collaboration with the Swiss HIV Cohort Study and IBM Research Zurich, I have been involved in a large machine learning study to develop and validate different...

Continue reading >>

Real-World Studies During International Emergencies and Beyond

Along with researchers from the University of Basel and Zürich, I have recently written an article about off-label treatments during pandemics: These treatment decisions...